BioCentury
ARTICLE | Financial News

Nabriva completes venture financing

April 13, 2015 7:00 AM UTC

Nabriva Therapeutics AG, Vienna, Austria Business: Infectious Date completed: 2015-04-07 Type: Venture financing Raised: $50 million Investors: Vivo Capital; OrbiMed Advisors; EcoR1 Capital; Tavistock...